Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer

References

1. 1.↵
   National Cancer Institute. Cancer Stat Facts: Thyroid Cancer. http://seer.cancer.gov/statfacts/html/thyro.html. Accessed April 20, 2017
2. 2.↵
   2. Davies L,
   3. Welch HG

   . Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014;140:317–22 doi:10.1001/jamaoto.2014.1 pmid:24557566

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Enewold L,
   3. Zhu K,
   4. Ron E, et al

   . Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 2009;18:784–91 doi:10.1158/1055-9965.EPI-08-0960 pmid:19240234

   Abstract/FREE Full Text
4. 4.↵
   2. Haugen BR,
   3. Alexander EK,
   4. Bible KC, et al

   . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133 doi:10.1089/thy.2015.0020 pmid:26462967

   CrossRefPubMed
5. 5.↵
   2. Rosário P,
   3. Tavares W,
   4. Borges M, et al

   . Ultrasonographic differentiation of cervical lymph nodes in patients with papillary thyroid carcinoma after thyroidectomy and radioiodine ablation: a prospective study. Endocr Pract 2014;20:293–98 doi:10.4158/EP13307.OR pmid:24246348

   CrossRefPubMed
6. 6.↵
   2. Leboulleux S,
   3. Girard E,
   4. Rose M, et al

   . Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92:3590–94 doi:10.1210/jc.2007-0444 pmid:17609301

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Landry CS,
   3. Grubbs EG,
   4. Busaidy NL, et al

   . Cystic lymph nodes in the lateral neck as indicators of metastatic papillary thyroid cancer. Endocr Pract 2011;17:240–44 doi:10.4158/EP10134.OR pmid:20713342

   CrossRefPubMed
8. 8.↵
   2. Sohn YM,
   3. Kwak JY,
   4. Kim EK, et al

   . Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. AJR Am J Roentgenol 2010;194:38–43 doi:10.2214/AJR.09.3128 pmid:20028903

   CrossRefPubMed
9. 9.↵
   2. Patel NU,
   3. McKinney K,
   4. Kreidler SM, et al

   . Ultrasound-based clinical prediction rule model for detecting papillary thyroid cancer in cervical lymph nodes: a pilot study. J Clin Ultrasound 2016;44:143–51 doi:10.1002/jcu.22309 pmid:26402153

   CrossRefPubMed
10. 10.↵
    2. Som PM,
    3. Curtin HD,
    4. Mancuso AA

    . Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 2000;174:837–44 doi:10.2214/ajr.174.3.1740837 pmid:10701636

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Torres MR,
    3. Nóbrega Neto SH,
    4. Rosas RJ, et al

    . Thyroglobulin in the washout fluid of lymph-node biopsy: what is its role in the follow-up of differentiated thyroid carcinoma? Thyroid 2014;24:7–18 doi:10.1089/thy.2013.0244 pmid:24044517

    CrossRefPubMed
12. 12.↵
    2. Snozek CL,
    3. Chambers EP,
    4. Reading CC, et al

    . Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab 2007;92:4278–81 doi:10.1210/jc.2007-1075 pmid:17684045

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Moon JH,
    3. Kim YI,
    4. Lim JA, et al

    . Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab 2013;98:1061–68 doi:10.1210/jc.2012-3291 pmid:23393171

    CrossRefPubMed
14. 14.↵
    2. Pepe MS,
    3. Alonzo TA

    . Comparing disease screening tests when true disease status is ascertained only for screen positives. Biostatistics 2001;2:249–60 doi:10.1093/biostatistics/2.3.249 pmid:12933537

    CrossRefPubMed
15. 15.↵
    2. Mickey RM,
    3. Greenland S

    . The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125–37 doi:10.1093/oxfordjournals.aje.a115101 pmid:2910056

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Alzahrani AS,
    3. Alsuhaibani H,
    4. Salam SA, et al

    . Diagnostic accuracy of high-resolution neck ultrasonography in the follow-up of differentiated thyroid cancer: a prospective study. Endocr Pract 2005;11:165–71 doi:10.4158/EP.11.3.165 pmid:16239202

    CrossRefPubMed
17. 17.↵
    2. Aribaş BK,
    3. Arda K,
    4. Çiledağ N, et al

    . Predictive factors for detecting malignancy in central and lateral cervical lymph nodes in papillary carcinoma of the thyroid. Asia Pac J Clin Oncol 2011;7:307–14 doi:10.1111/j.1743-7563.2011.01408.x pmid:21884444

    CrossRefPubMed
18. 18.↵
    2. Chammas MC,
    3. Macedo TA,
    4. Lo VW, et al

    . Predicting malignant neck lymphadenopathy using color duplex sonography based on multivariate analysis. J Clin Ultrasound 2016;44:587–94 doi:10.1002/jcu.22380 pmid:27492569

    CrossRefPubMed
19. 19.↵
    2. Liu T,
    3. Su X,
    4. Chen W, et al

    . A mathematical model using computed tomography for the diagnosis of metastatic central compartment lymph nodes in papillary thyroid carcinoma. Eur Radiol 2014;24:2827–34 doi:10.1007/s00330-014-3335-2 pmid:25103534

    CrossRefPubMed